2017

Memo Therapeutics AG was awarded a new CTI grant
MEMO has secured a third CTI …

Memo Therapeutics AG announces proof of concept of its huMemoMABTM antibody technology platform
 
Basel/Zurich, Switzerland, May 23, …

MEMO at conferences
MEMO presented in the investment stream at SNB 2017 in Zurich this year. Link to the conference …